Holly R. Evans

Sheffield, ENG S102RX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease.

Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease.

Journal: JBMR plus

Published: March 22, 2024

Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.

Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.

Journal: Nature

Published: April 17, 2023

Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human.

Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: March 07, 2023

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.

Journal: Journal for immunotherapy of cancer

Published: December 30, 2022

ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation.

ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation.

Journal: Stem cell research & therapy

Published: September 15, 2020

Correction: LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution.

Correction: LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution.

Journal: Cancer research

Published: October 03, 2019

TGFβ Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance in a Murine Myeloma Model.

TGFβ Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance in a Murine Myeloma Model.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: May 17, 2019

PYY is a negative regulator of bone mass and strength.

PYY is a negative regulator of bone mass and strength.

Journal: Bone

Published: April 15, 2019

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: April 27, 2018

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.

Journal: PloS one

Published: January 16, 2018

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.

Journal: Nature communications

Published: September 21, 2017

An Essential Physiological Role for MCT8 in Bone in Male Mice.

An Essential Physiological Role for MCT8 in Bone in Male Mice.

Journal: Endocrinology

Published: April 24, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026